GoodCell Offers Personal Biobanking Early Adopter Discount for a Limited Time
Waltham, MA, June 13, 2022 (GLOBE NEWSWIRE) — Today, GoodCell, a life sciences company, is announcing a limited-time early adopter discount for Personal Biobanking, a proactive, preventative healthcare service that allows members to store their own stem cells for future potential personalized cell therapies. GoodCell’s Personal Biobanking—similar to cord blood banking—is a subscription service. With the […]
Vor Bio Successfully Demonstrates Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment Presented at EHA
CAMBRIDGE, Mass., June 10, 2022 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced successful first of its kind dual editing of CD33 and CLL-1 in human hematopoietic stem cells (HSCs) demonstrating continued progress on its novel approach for the treatment of acute myeloid leukemia (AML). The data […]
Seelos Therapeutics Announces Data Demonstrating Statistically Significant Downregulation of mRNA and Reduction of Alpha Synuclein in an In Vitro Gene Therapy Study of SLS-004 Utilizing CRISPR-dCas9 in Dementia with Lewy Bodies
NEW YORK, June 9, 2022 /PRNewswire/ — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced data demonstrating a statistically significant (p<0.01) 19% downregulation of mRNA and a ~40% reduction of alpha synuclein (α-synuclein) in an in vitro study […]
UTSA awards $4 million to Oskar Fischer Prize recipients for innovative explanations of Alzheimer’s disease
SAN ANTONIO, June 8, 2022 /PRNewswire/ — The University of Texas at San Antonio (UTSA) today announced the 10 recipients of the Oskar Fischer Prize, an international competition to expand society’s understanding of the causes of Alzheimer’s disease. The prize, the world’s largest of its kind, totals $4 million in gold, silver and bronze categories, […]
Stem cells helping patients with Parkinson’s Disease
News segment from Houston’s KPRC talking about the first FDA approved stem cell trial that is happening to help patient’s dealing with Parkinson’s Disease. Video Transcript: More than 10 million people worldwide are living with Parkinson’s and 60,000 are in the U.S.. It’s a chronic progressive disease, which means it gets worse over time. But […]
The Impact of T Cells in Neurodegenerative Disease and Regenerative Therapies
UCI Sue and Bill Gross Stem Cell Research Center Lecture by Craig Walsh, Ph.D. talking a little bit about the immune system and how particular types of cells of the immune system called T cells; the roles that they play in neurodegenerative diseases, and talk about multiple sclerosis and Alzheimer’s disease. And in particular how […]
2022 WMIF | The Cell Therapy Landscape | CAR-T to Stem Cells
Cell therapies, ranging from CAR-T cells to stem-cell-based approaches, are emerging as a transformative therapeutic modality. Panelists will examine this emerging landscape and discuss a range of key topics. What drives differentiation in this space given the high number of competing technologies? How will the uptake of autologous cell therapies and allogeneic versions evolve? When […]
Study Shows Effectiveness of Merakris’ Wound Care Products
RESEARCH TRIANGLE PARK, N.C., June 02, 2022 (GLOBE NEWSWIRE) — A peer-reviewed case study in the May 21 edition of SAGE Open Medical Case Reports highlights the effectiveness of two Merakris Therapeutics wound care products – Dermacyte® Amniotic Wound Care Liquid and Dermacyte® Amniotic Wound Care Matrix – in treating non-healing venous leg ulcers. The […]
What is Gene Therapy?
Gene therapy has been studied for more than 40 years and can help stop or slow the effects of disease on the most basic level of the human body—our genes. And to understand how it works, we’ll start at the basics. Here’s a great video from the American Society for Gene & Cell Therapy to […]
Biorep Technologies, Inc. Joins the Tetra Partner Network to Accelerate Research into Stem-Cell Derived Insulin to Cure Diabetes
BOSTON, May 31, 2022 /PRNewswire/ — TetraScience, the R&D Data Cloud company, announced today that Biorep Technologies, Inc., the leading provider of scientific instruments that help pharmaceutical companies and leading universities research cures for Type 1 and Type 2 diabetes, has joined the Tetra Partner Network. The partnership builds on a joint deployment of Biorep’s […]